C. Galmarini
发表
B. Bouchet,
C. Caron de Fromentel,
A. Puisieux,
2006,
Critical reviews in oncology/hematology.
C. Galmarini,
O. Trédan,
F. Galmarini,
2015,
Medical Oncology.
Luis García Fernández,
C. Galmarini,
M. Aracil,
2013
.
I. Tannock,
C. Galmarini,
O. Trédan,
2007,
Journal of the National Cancer Institute.
D. Busch,
H. Einsele,
M. Dhodapkar,
1987,
Hearing Research.
C. Galmarini,
2020,
International journal of chronic diseases.
C. Galmarini,
C. Dumontet,
L. Jordheim,
2004,
Leukemia & lymphoma.
C. Galmarini,
Christian Chena,
I. Slavutsky,
2000,
Acta Haematologica.
B. Bouchet,
A. Puisieux,
C. Galmarini,
2007,
Cancer biology & therapy.
M. Zucchetti,
P. Allavena,
A. Mantovani,
2013,
Cancer cell.
A. Escargueil,
C. Galmarini,
J. Henriques,
2016,
Oncotarget.
B. Bouchet,
A. Puisieux,
C. Galmarini,
2011,
European journal of cell biology.
Synthesis and antiproliferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives.
C. Galmarini,
F. Kozielski,
F. Popowycz,
2009,
Bioorganic & medicinal chemistry.
P. Allavena,
A. Mantovani,
C. Galmarini,
2017,
British Journal of Cancer.
C. Galmarini,
J. F. Martínez-Leal,
M. Lillo,
2018,
Scientific Reports.
C. Galmarini,
M. Lucius,
M. Belvisi,
2020,
medRxiv.
L. Paz-Ares,
C. Galmarini,
A. Farago,
2019,
Future oncology.
C. Galmarini,
J. F. Martínez-Leal,
S. Munt,
2018,
Molecular Cancer Therapeutics.
C. Galmarini,
M. Pollán,
A. Muñoz,
2013,
Marine drugs.
I. Barasoain,
C. Galmarini,
M. Peñalva,
2013,
ACS chemical biology.
C. Galmarini,
C. Dumontet,
L. Jordheim,
2003,
Expert review of anticancer therapy.
V. Hervieu,
A. Puisieux,
C. Galmarini,
2003,
British Journal of Cancer.
C. Galmarini,
G. Roodman,
N. Kurihara,
2019,
Oncotarget.
J. Szöllősi,
C. Galmarini,
R. Rühl,
2013,
Marine drugs.
C. Galmarini,
F. Kozielski,
Q. Do,
2009,
Journal of medicinal chemistry.
J. Mackey,
C. Galmarini,
C. Dumontet,
2004,
BMC pharmacology.
J. Mackey,
A. Puisieux,
C. Galmarini,
2002,
International journal of cancer.
C. Galmarini,
C. Dumontet,
L. Jordheim,
2005,
Molecular Cancer Therapeutics.
J. Mackey,
C. Galmarini,
C. Dumontet,
2004,
Clinical Cancer Research.
C. Galmarini,
C. Dumontet,
L. Jordheim,
2006,
Nucleosides, nucleotides & nucleic acids.
C. Galmarini,
S. Vinogradov,
G. Warren,
2010,
International journal of pharmaceutics.
C. Galmarini,
2007,
Leukemia research.
C. Galmarini,
C. Dumontet,
L. Jordheim,
2003,
Leukemia & lymphoma.
Enrique J. deAndrés-Galiana,
A. Kloczkowski,
J. Fernández-Martínez,
2022,
Computers in Biology and Medicine.
C. Galmarini,
C. Dumontet,
L. Jordheim,
2005,
Leukemia & lymphoma.
C. Galmarini,
M. D’Incalci,
A. Larsen,
2016,
Cancer Chemotherapy and Pharmacology.
G. Peters,
C. Galmarini,
M. Sandvold,
2010,
Nucleosides, nucleotides & nucleic acids.
P. Allavena,
C. Galmarini,
M. D’Incalci,
2013,
International journal of cancer.
Juan A. Bueren-Calabuig,
J. Bueren-Calabuig,
F. Gago,
2009,
Biochemical pharmacology.
C. Galmarini,
2006,
Haematologica.
C. Galmarini,
M. D’Incalci,
2010,
Molecular Cancer Therapeutics.
F. Gago,
C. Galmarini,
J. Bueren,
2013,
British journal of pharmacology.
Juan A. Bueren-Calabuig,
J. Bueren-Calabuig,
F. Gago,
2010,
British journal of pharmacology.
C. Galmarini,
D'Incalci,
2010
.
C. Galmarini,
M. D’Incalci,
2010
.
C. Galmarini,
M. D’Incalci,
2010
.
C. Galmarini,
D'Incalci,
2010
.
I. Barasoain,
B. Bouchet,
C. Galmarini,
2014,
Biochemical pharmacology.
C. Galmarini,
C. Dumontet,
X. Thomas,
2005
.
C. Galmarini,
C. Dumontet,
X. Thomas,
2005,
Haematologica.
C. Galmarini,
C. Dumontet,
X. Thomas,
2002,
Leukemia research.
C. Galmarini,
Y. Bertrand,
M. Ffrench,
2007,
Leukemia research.
C. Galmarini,
S. Munt,
P. Avilés,
2011
.
I. Bièche,
E. Raymond,
C. Galmarini,
2013,
Marine drugs.
E. Raymond,
C. Galmarini,
S. Faivre,
2007,
British Journal of Cancer.
F. Gago,
C. Galmarini,
J. F. Martínez-Leal,
2016,
Scientific Reports.
A. Puisieux,
C. Galmarini,
N. Falette,
2003,
Biochemical pharmacology.
B. Bouchet,
A. Puisieux,
C. Galmarini,
2006,
International journal of cancer.
C. Galmarini,
C. Dumontet,
François Roy,
2004,
Oncogene.
C. Galmarini,
M. F. Palacios,
P. Baré,
2001,
Journal of human virology.
C. Galmarini,
C. Dumontet,
L. Jordheim,
2006,
Recent patents on anti-cancer drug discovery.
C. Galmarini,
O. Trédan,
F. Galmarini,
2014,
Cancer and Metastasis Reviews.
C. Galmarini,
T. Martínez,
A. Muñoz,
2009,
Current opinion in investigational drugs.
C. Galmarini,
F. Galmarini,
2003,
Current opinion in investigational drugs.
C. Galmarini,
F. Popowycz,
T. Besson,
2007,
Bioorganic & medicinal chemistry.
J. Mackey,
C. Galmarini,
C. Dumontet,
2002,
The Lancet. Oncology.
P. Allavena,
C. Galmarini,
M. D’Incalci,
2014,
British Journal of Cancer.
Juan A. Bueren-Calabuig,
J. Bueren-Calabuig,
F. Gago,
2011,
Chemistry & biology.
C. Galmarini,
M. Peñalva,
Areti Pantazopoulou,
2018,
Scientific Reports.
C. Galmarini,
F. Popowycz,
B. Joseph,
2008,
Current medicinal chemistry.
C. Galmarini,
C. Dumontet,
X. Thomas,
2002,
British journal of haematology.
C. Galmarini,
C. Dumontet,
L. Jordheim,
2006,
Cancer Chemotherapy and Pharmacology.
Carlos M Galmarini,
C. Galmarini,
F. Galmarini,
2012,
Critical reviews in oncology/hematology.
C. Galmarini,
M. Sandvold,
F. Myhren,
2009,
British journal of haematology.
C. Galmarini,
E. Kohli,
S. Vinogradov,
2008,
Molecular Cancer Therapeutics.
J. Mackey,
C. Galmarini,
C. Dumontet,
2001,
Blood.
C M Galmarini,
M D'Incalci,
F. Grosso,
2014,
Oncogene.
J. Baselga,
J. Garber,
N. Tung,
2018,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
A. Puisieux,
C. Galmarini,
N. Falette,
2001,
British Journal of Cancer.
C. Galmarini,
M. D’Incalci,
E. Erba,
2013
.
P. Allavena,
A. Mantovani,
F. Grosso,
2010,
Cancer research.
C. Galmarini,
J. F. Martínez-Leal,
J. Egly,
2016,
Molecular Cancer Therapeutics.
A. Puisieux,
C. Galmarini,
Qing Wang,
2005,
Familial Cancer.
J. Mora,
C. Teodosio,
D. Herrero-Martín,
2017,
OncoTarget.
C. Galmarini,
C. Dumontet,
L. Jordheim,
2003,
Biochemical pharmacology.
C. Galmarini,
L. García-Fernández,
Sonia Ávila-Arroyo,
2015,
Journal of breast cancer.
J. Mora,
C. Teodosio,
D. Herrero-Martín,
2017,
Oncotarget.
A. Puisieux,
C. Galmarini,
F. Fauvet,
2011,
European journal of cell biology.
C M Galmarini,
M Lucius,
C. Galmarini,
2020,
European review for medical and pharmacological sciences.
C. Galmarini,
F. Galmarini,
D. Galmarini,
2000,
Microcirculation.
C. Galmarini,
2002,
Journal of experimental therapeutics & oncology.
I. Ray-Coquard,
C. Galmarini,
D. Berton‐Rigaud,
2017,
Annals of oncology : official journal of the European Society for Medical Oncology.
Joseph T. Roland,
G. Hostetter,
L. Turner,
2016,
Cancer research.
Joseph T. Roland,
G. Hostetter,
C. Galmarini,
2016
.
A. Escargueil,
C. Galmarini,
A. Sarasin,
2011,
Molecular Cancer Therapeutics.
P. Allavena,
C. Galmarini,
M. D’Incalci,
2014,
Marine drugs.
C. Galmarini,
M. D’Incalci,
E. Erba,
2015,
British Journal of Cancer.
X. Chen,
J. Montero,
A. Pandiella,
2009,
Blood.
C. Galmarini,
R. Rosenstein,
R. Gamberale,
2008,
Biochemical pharmacology.
J. Mackey,
C. Galmarini,
C. Dumontet,
2003,
British journal of haematology.
B. Monk,
C. Galmarini,
S. Kaye,
2014,
Gynecologic oncology.
C. Galmarini,
2020,
EXCLI journal.
C. Galmarini,
A. Aguilera,
E. Tumini,
2018,
Molecular Cancer Research.
F. Gago,
C. Galmarini,
J. F. Martínez-Leal,
2018,
British Journal of Cancer.
Luis García Fernández,
C. Galmarini,
J. Leal,
2013,
International journal of clinical and experimental pathology.
J. Mackey,
C. Cass,
C. Galmarini,
2005,
Blood.
S. Pilotti,
C. Galmarini,
M. D’Incalci,
2017,
BMC Cancer.
J. Mackey,
C. Cass,
C. Galmarini,
2004
.
J. Mackey,
C. Cass,
C. Galmarini,
2004
.
D. Larsimont,
M. Piccart,
F. Cardoso,
2008,
Clinical Cancer Research.
M. Lucius,
J. De All,
J. A. De All,
2020,
medRxiv.
C. Galmarini,
2006,
Current opinion in investigational drugs.
A. Escargueil,
C. Galmarini,
A. Sarasin,
2011
.
C. Galmarini,
F. Galmarini,
D. Galmarini,
2002,
Medical oncology.
M. Cazzola,
P. Allavena,
C. Galmarini,
2017,
British Journal of Cancer.
M. Hidalgo,
P. Allavena,
R. Mangues,
2016,
Disease Models & Mechanisms.
J. Mackey,
C. Galmarini,
C. Dumontet,
2003,
International journal of cancer.
C. Galmarini,
F. Bontemps,
J. Balzarini,
2006,
Nucleosides, nucleotides & nucleic acids.
E. Álava,
J. Miguel,
J. Montero,
2008
.
Maud Martin,
A. Akhmanova,
C. Galmarini,
2018,
BMC Cancer.
Juan A. Bueren-Calabuig,
J. Bueren-Calabuig,
F. Gago,
2011,
Nucleic acids research.
F. Gago,
C. Galmarini,
L. García-Fernández,
2014
.
C. Galmarini,
S. Munt,
P. Avilés,
2014
.
C. Galmarini,
M. Lillo,
A. Losada,
2014
.
C. Galmarini,
J. F. Martínez-Leal,
V. Moneo,
2014
.
C. Galmarini,
F. Galmarini,
D. Galmarini,
2002,
American journal of clinical oncology.
C. Galmarini,
2009,
Current opinion in investigational drugs.
C. Galmarini,
P. Nannini,
C. Jancic,
2012,
Investigational New Drugs.
C. Galmarini,
J. F. Martínez-Leal,
M. Lillo,
2015,
PloS one.
C. Galmarini,
B. P. Bouchet,
2010,
Drugs of today.
S. Pilotti,
C. Galmarini,
M. D’Incalci,
2017,
BMC Cancer.
A. Puisieux,
C. Galmarini,
N. Falette,
2007,
British Journal of Cancer.
J. Mackey,
C. Galmarini,
C. Dumontet,
2004,
Haematologica.
C. Galmarini,
G. Vereb,
P. Nagy,
2011,
European journal of pharmacology.
C. Galmarini,
J. F. Martínez-Leal,
M. Lillo,
2011,
PloS one.
Maud Martin,
A. Akhmanova,
C. Galmarini,
2018,
BMC Cancer.
C. Galmarini,
R. Ruggiero,
P. Chiarella,
2022,
Frontiers in Oncology.
J. Mora,
C. Teodosio,
D. Herrero-Martín,
2015,
Oncotarget.
J. Mackey,
C. Galmarini,
C. Dumontet,
2001,
Leukemia.
P. Allavena,
C. Galmarini,
M. D’Incalci,
2016
.
F. Gago,
C. Galmarini,
M. Muñoz-Alonso,
2018,
British Journal of Cancer.
C. Galmarini,
O. Trédan,
F. Galmarini,
2013,
Cancer and Metastasis Reviews.
M. Hidalgo,
P. Allavena,
R. Mangues,
2016,
Disease Models & Mechanisms.
F. Gago,
C. Galmarini,
J. Bueren,
2013,
British journal of pharmacology.
C. Cass,
C. Galmarini,
D. Glubrecht,
2013
.
X. Chen,
E. Colado,
J. Flores-Montero,
2011,
Haematologica.
X. Chen,
J. Montero,
A. Pandiella,
2009,
Blood.